Search for: "DOW PHARMACEUTICAL SCIENCES, INC." Results 61 - 80 of 131
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Feb 2024, 12:07 pm by admin
Any opinion that “can be tested is science”; end of discussion. [read post]
24 Mar 2020, 3:44 pm by John Jascob
In about that same time frame, said the complaint, the Dow Jones Industrial Average had peaked at a record level of over 29,551 but had lost one-third of its value as of the time the complaint was filed. [read post]
1 May 2008, 11:21 am
Beretta USA, Inc., No. 05-6942-cv (2d Cir. [read post]
5 Jan 2022, 4:33 am by Jon L. Gelman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993).Where does the universe of disability terminate? [read post]
3 May 2022, 10:28 am by Eugene Volokh
Merrell Dow Pharmaceuticals, Inc. (1993), the Supreme Court explained that Rule 702 imposes an obligation on a trial court to act as gatekeeper, to ensure that any and all scientific [or technical or otherwise specialized] testimony or evidence admitted is not only relevant, but reliable. [read post]
24 Dec 2012, 9:58 am by Schachtman
Merrell Dow Pharmaceuticals Inc., 509 U.S. 579 (1993), a case that has been superseded by subsequent cases and a revision to the operative statute, Rule 702. [read post]
28 May 2015, 2:29 pm by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 593 (1993). [read post]
5 Jun 2013, 5:29 am by Schachtman
Oct. 24, 1996) Merrell Dow Pharms., Inc. v. [read post]
28 Feb 2024, 2:00 pm
Merrell Dow Pharms., Inc. (1993) 509 U.S. 579, 593 (Daubert); see also Primiano v. [read post]
8 May 2020, 3:47 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [2]  Frye v. [read post]
12 Oct 2021, 6:35 am by Natalie DiFelice
She has worked on many pharmaceutical products liability cases and acted as defense counsel for Merrell Dow Pharmaceuticals, Inc. [read post]